GL1X · GenesisL1 explorer

Research workbench

Pyrr of mycobacterium tuberculosis as a potential drug target

Analyse Pyrr of mycobacterium tuberculosis as a potential drug target in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1W30
Type
protein
Length
351 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyrr bifunctional protein
EC
2.4.2.9
UniProt
P71807
Pockets
6 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APyrr bifunctional protein (EC 2.4.2.9)protein17432% helix, 29% strandP71807
BPyrr bifunctional protein (EC 2.4.2.9)protein17732% helix, 28% strandP71807

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.510.8715empty
2860.430.7918empty
31150.370.7423empty
4980.350.7419empty
5850.340.7521empty

Interfaces

1 interface between chains.

  • A–B · 871 Ų buried · 26 hydrogen bonds · protein-protein

Compared structures

  • 1W30 · PyrR of Mycobacterium Tuberculosis as a potential drug target · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.